Education
About Us
Working with TipRanks
Follow Us
Theralase Technologies (TSE:TLT)
:TLT
TLT Stock Chart & Stats
C$0.16
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.16
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.15 - C$0.34
Previous CloseN/A
Volume127.37K
Average Volume (3M)121.23K
Market Cap
C$39.84M
Enterprise ValueC$0.00
Total Cash (Recent Filing)C$80.99K
Total Debt (Recent Filing)C$319.72K
Price to Earnings (P/E)―
Beta-0.82
Next Earnings
Apr 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding257,058,320
10 Day Avg. Volume149,922
30 Day Avg. Volume121,227
Financial Highlights & Ratios
PEG Ratio1.00
Price to Book (P/B)30.77
Price to Sales (P/S)61.56
P/FCF Ratio-19.01
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Theralase Technologies News
TLT FAQ
What was Theralase Technologies’s price range in the past 12 months?
Theralase Technologies lowest stock price was C$0.15 and its highest was C$0.34 in the past 12 months.
What is Theralase Technologies’s market cap?
Theralase Technologies’s market cap is C$39.84M.
When is Theralase Technologies’s upcoming earnings report date?
Theralase Technologies’s upcoming earnings report date is Apr 29, 2026 which is in 128 days.
How were Theralase Technologies’s earnings last quarter?
Theralase Technologies released its earnings results on Nov 10, 2025. The company reported -C$0.004 earnings per share for the quarter, missing the consensus estimate of -C$0.003 by -C$0.001.
Is Theralase Technologies overvalued?
According to Wall Street analysts Theralase Technologies’s price is currently Overvalued.
Does Theralase Technologies pay dividends?
Theralase Technologies does not currently pay dividends.
What is Theralase Technologies’s EPS estimate?
Theralase Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Theralase Technologies have?
Theralase Technologies has 257,058,320 shares outstanding.
What happened to Theralase Technologies’s price movement after its last earnings report?
Theralase Technologies reported an EPS of -C$0.004 in its last earnings report, missing expectations of -C$0.003. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Theralase Technologies?
Currently, no hedge funds are holding shares in TSE:TLT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Theralase Technologies
Theralase Technologies Inc. is a Canadian-based biotechnology company specializing in the development of innovative medical technologies, particularly in the field of photodynamic therapy (PDT) for cancer treatment and pain management. The company is focused on creating advanced therapeutic solutions that utilize its proprietary laser technology and drug formulations to improve patient outcomes in oncology and other health sectors.
Technical Analysis
Aurora Spine
―
Perimeter Medical Imaging AI
―
VentriPoint Diagnostics
―
Cannabix Technologies
―
Therma Bright
―
Options Prices
Currently, No data available
---